Bank Of New York Mellon Corp Avenue Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$2.95 - $11.04 $734 - $2,748	-249 Reduced 1.65%	14,848 $88,000
Q3 2020 Nov 12, 2020	BUY	$9.37 - $12.06 $609 - $783	65 Added 0.43%	15,097 $163,000
Q2 2020 Aug 12, 2020	BUY	$8.29 - $11.47 $124,615 - $172,417	15,032 New	15,032 $161,000

Ticker ATXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,127,720
Market Cap $8.59M
Description
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.